Harvard Bioscience Director Adds $103,603 in HBIO Stock Across Two Trades
Harvard Bioscience director William Snider purchased a total of $103,603 of common stock in two transactions on March 16-17, 2026. After the purchases he now directly holds 32,000 shares. The insider buying comes as the stock trades below analyst targets and the company posted Q4 2025 revenue of $23.7 million while issuing modest growth guidance fo…